6 completed, 2 recruiting, 1 not yet recruiting. 9 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 6, Recruiting 2, Not yet recruiting 1 |
Follow Urinalysis: new trials by email Literature Review of Urinalysis trials Research Report on Urinalysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset | Phase 1 | Not yet recruiting | Columbia University | 6 | 2027-08-01 | 2026-05-13 |
| Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers Psilocybin and D-Serine, Physical Examination, Vital signs - Healthy Volunteers | Phase 1 | Recruiting | Hadassah Medical Organization | 10 | 2025-12-11 | 2026-02-05 |
| UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients Physical examination, Electrocardiogram, SF-36 questionnaire - SLE, Lupus | Phase 1 | Recruiting | LiveKidney.Bio | 10 | 2025-01-07 | 2025-09-11 |
| Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC KM-001 cream 1% 12 weeks treatment., Physical Examination, Vital Signs - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 18 | 2023-03-06 | 2025-01-15 |
| Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases Serum chemistry, Hematology, Urinalysis - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 14 | 2022-07-17 | 2025-01-07 |
| KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) IMP Application KM-001, Chemistry, Hematology - Lichen Simplex Chronicus | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 55 | 2022-05-24 | 2024-04-02 |
| Oral Nifedipine to Treat Iron Overload Nifedipine, Phlebotomy, Urinalysis - Thalassemia, Iron Overload | Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 | 2008-06-20 | 2017-07-02 |
| Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) Blood Test, Urine Test, Physical Exam - Healthy | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2004-12-09 | 2017-07-02 |
| Anthrax Vaccine Clinical Trials Anthrax Vaccine, Blood Chemistry, Hematology - Anthrax | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 93 | 2004-09-08 | 2017-07-02 |
Keratosis palmoplantaris papulosa (2) · Pachyonychia Congenita (2) · Alzheimer Disease (1) · Anthrax (1) · Coronavirus Infections (1) · Hemochromatosis (1) · Iron Overload (1) · Lupus Erythematosus, Systemic (1) · Neurodermatitis (1) · Thalassemia (1) · Virus Diseases (1)
Orvida Pharma (formerly Kamari Pharma) (3) · Columbia University (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Hadassah Medical Organization (1) · LiveKidney.Bio (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
United States (5) · Israel (2) · Germany (1) · United Kingdom (1)
Clay W. Mash, Ph.D. (1) · Grace McIlvain, PhD (1)